Targeted fetal cell‐free DNA screening for aneuploidies in 4,594 pregnancies: Single center study

Targeted fetal cell‐free DNA screening for aneuploidies in 4,594 pregnancies: Single center study

Abstract Background Next‐generation sequencing (NGS) and discovery of fetal cell‐free DNA (cfDNA) in the maternal circulation render possible prenatal screening for trisomy 21 (Down syndrome), trisomy 18, trisomy 13, and sex chromosome aneuploidies. The approach is called “fetal cfDNA screening” and...

Full description

Bibliographic Details
Main Authors: Altug Koc, Ozge Ozer Kaya, Berk Ozyilmaz, Yasar B. Kutbay, Ozgur Kirbiyik, Taha R. Ozdemir, Kadri M. Erdogan, Merve Saka Guvenc, Deniz C. Oztekin, Mehmet Ozeren, Halil G. Pala, Atalay Ekin, Cenk Gezer, Alkim G. Sahingoz Yildirim, Bahar Konuralp Atakul, Secil Kurtulmus, Ugur Turhan, Cuneyt E. Taner
Format: Article
Language:English
Published: Wiley 2019-07-01
Series:Molecular Genetics & Genomic Medicine
Subjects:
cfDNA screening
NIPS
NIPT
Online Access:https://doi.org/10.1002/mgg3.678

Internet

https://doi.org/10.1002/mgg3.678

Similar Items